Compare LyondellBasell Industries NV (LYB) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LyondellBasell Industries NV vs Teladoc Health Inc — how do they compare? LyondellBasell Industries NV trades at $63.87 (market cap $20.67B), while Teladoc Health Inc trades at $6.67 (market cap $1.24B). The key difference: LyondellBasell Industries NV is far larger — about 16.7× Teladoc Health Inc's market cap, and LyondellBasell Industries NV pays a 6.44% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| LYB | TDOC | |
|---|---|---|
Market Cap | $20.67B | $1.24B |
Sector | Basic Materials | Health |
52-Week High | $82.38 | $9.72 |
52-Week Low | $42.28 | $4.47 |
Enterprise Value | $32.26B | $1.50B |
Dividend Yield | 6.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LyondellBasell Industries (LYB) trades at $62.79, up 0.22% today, with a bullish technical outlook supported by moving averages. Recent Q2 2026 earnings beat expectations with EPS of $4.30 versus $3.44 estimated, driven by improved margins from supply disruptions. However, 2025 fundamentals show challenges, including a net loss of $745 million and negative profit margins, though cash flow from operations remains positive at $2.26 billion.
The stock offers potential upside to the $70.56 analyst consensus target, with 46% of analysts rating it a buy, but faces risks from volatile chemical markets and high debt. Investor sentiment is mixed amid earnings recovery signs and macroeconomic pressures on demand.
Teladoc Health (TDOC) trades at $6.62, down 6.5% on the day, reflecting investor concern after a Q2 2026 revenue miss and lowered full-year guidance. The stock is technically bearish with key support at $6, while fundamentals show revenue of $2.53B in 2025 but persistent net losses, with a negative net income margin of -7.13%. Recent news highlights multiple law firm investigations into the company following its guidance cut.
The outlook remains challenging due to weak BetterHelp performance and ongoing losses, though valuation ratios like P/S of 0.49 and EV/EBITDA of 6.96 suggest potential undervaluation. Risks include competitive pressures and legal scrutiny, but analyst consensus price target of $8.88 implies upside if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
